S-8 S-8 EX-FILING FEES 0000890821 Enveric Biosciences, Inc. N/A Fees to be Paid 0000890821 2026-05-29 2026-05-29 0000890821 1 2026-05-29 2026-05-29 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-8

Enveric Biosciences, Inc.

Table 1: Newly Registered Securities

Security Type

Security Class Title

Fee Calculation Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

1 Equity Common Stock, par value $0.01 per share ("Common Stock") Other 553,784 $ 2.1825 $ 1,208,633.58 0.0001381 $ 166.91

Total Offering Amounts:

$ 1,208,633.58

$ 166.91

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 166.91

Offering Note

1

Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), the number of shares registered hereunder includes such additional number of shares of common stock, par value $0.01 per share (the "Common Stock") of Enveric Biosciences, Inc. (the "Company"), as are required to prevent dilution resulting from a stock split, stock dividend or similar transaction. The offering price has been estimated solely for the purposes of the calculation of the registration fee. The offering price has been calculated in accordance with the manner described in paragraphs (c) and (h) of Rule 457 under the Securities Act and is based upon the average of high ($2.235) and low ($2.1825) prices reported by the Nasdaq Capital Market on May 27, 2026, a date within five (5) business days prior to the date of the filing of this Registration Statement.

Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rule 457(p)
Fee Offset Claims
Fee Offset Sources